<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38491011</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts.</ArticleTitle><Pagination><StartPage>2363</StartPage><MedlinePgn>2363</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-46451-0</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection in children and young people (CYP) can lead to life-threatening COVID-19, transmission within households and schools, and the development of long COVID. Using linked health and administrative data, we investigated vaccine uptake among 3,433,483 CYP aged 5-17&#x2009;years across all UK nations between 4th August 2021 and 31st May 2022. We constructed national cohorts and undertook multi-state modelling and meta-analysis to identify associations between demographic variables and vaccine uptake. We found that uptake of the first COVID-19 vaccine among CYP was low across all four nations compared to other age groups and diminished with subsequent doses. Age and vaccination status of adults living in the same household were identified as important risk factors associated with vaccine uptake in CYP. For example, 5-11&#x2009;year-olds were less likely to receive their first vaccine compared to 16-17&#x2009;year-olds (adjusted Hazard Ratio [aHR]: 0.10 (95%CI: 0.06-0.19)), and CYP in unvaccinated households were less likely to receive their first vaccine compared to CYP in partially vaccinated households (aHR: 0.19, 95%CI 0.13-0.29).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aldridge</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-5158-1242</Identifier><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK. s.j.aldridge@swansea.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Utkarsh</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Siobh&#xe1;n</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millington</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0814-0801</Identifier><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almaghrabi</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Sneha N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedston</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goudie</LastName><ForeName>Rosalind</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Rowena</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joy</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowthian</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Education and Childhood Studies, School of Social Sciences, Swansea University, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lusignan</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8553-2641</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Lynsey</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Agency, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6848-5241</Identifier><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, Strathclyde University, Glasgow, UK and Public Health Scotland, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudan</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre for Global Health, Usher Institute, the University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>Declan T</ForeName><Initials>DT</Initials><Identifier Source="ORCID">0000-0003-1468-1823</Identifier><AffiliationInfo><Affiliation>Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Agency, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Ronan A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0001-5225-000X</Identifier><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Rhiannon K</ForeName><Initials>RK</Initials><Identifier Source="ORCID">0000-0001-5977-376X</Identifier><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK. r.k.owen@swansea.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SBF006\1122</GrantID><Acronym>DUK_</Acronym><Agency>Diabetes UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>AS has served on a number of UK and Scottish government COVID-19 advisory bodies. CR has served on a number of UK and Scottish government COVID-19 advisory bodies&#x2014;SPI-M, MHRA Covid Vaccines Benefit and Risk Group, Scottish Government Covid Advisory Group and Chief Nursing Officer Nosocomial Advisory Group. DTB has served on a number of UK and Northern Ireland government COVID-19 advisory bodies. All other authors report no competing interests. RAL was a member of the Welsh Government COVID-19 Technical Advisory Group. RKO is a member of the National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee, member of the NICE Decision Support Unit (DSU), and associate member of the NICE Technical Support Unit (TSU). RKO has served as a paid consultant to the pharmaceutical industry, providing unrelated methodological advice generally. She reports teaching fees from the Association of British Pharmaceutical Industry (ABPI) and the University of Bristol. SdeL has received grants through his University for vaccine related research from AstraZeneca, GSK, Moderna, MSD, Sanofi and Seqirus. He has also been a member of advisory boards for AstraZeneca, GSK, Sanofi and Seqirus, with any funding paid to his University. The remaining authors have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>16</Day><Hour>21</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>16</Day><Hour>0</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38491011</ArticleId><ArticleId IdType="pmc">PMC10943015</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-46451-0</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-46451-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr. Infect. Dis. J. 2020;39:355&#x2013;368. doi: 10.1097/INF.0000000000002660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002660</ArticleId><ArticleId IdType="pmc">PMC7158880</ArticleId><ArticleId IdType="pubmed">32310621</ArticleId></ArticleIdList></Reference><Reference><Citation>Castagnoli R, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174:882&#x2013;889. doi: 10.1001/jamapediatrics.2020.1467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1467</ArticleId><ArticleId IdType="pubmed">32320004</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc. Health. 2020;4:669&#x2013;677. doi: 10.1016/S2352-4642(20)30215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30215-7</ArticleId><ArticleId IdType="pmc">PMC7347350</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId></ArticleIdList></Reference><Reference><Citation>Watermeyer R, Crick T, Knight C, Goodall J. COVID-19 and digital disruption in UK universities: afflictions and affordances of emergency online migration. High. Educ. 2021;81:623&#x2013;641. doi: 10.1007/s10734-020-00561-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10734-020-00561-y</ArticleId><ArticleId IdType="pmc">PMC7269686</ArticleId><ArticleId IdType="pubmed">32836334</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay AR, May T, Dawes J, Fancourt D, Burton A. You&#x2019;re just there, alone in your room with your thoughts&#x2019;: a qualitative study about the psychosocial impact of the COVID-19 pandemic among young people living in the UK. BMJ Open. 2022;12:e053676. doi: 10.1136/bmjopen-2021-053676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053676</ArticleId><ArticleId IdType="pmc">PMC8829834</ArticleId><ArticleId IdType="pubmed">35140155</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc. Health. 2020;4:421. doi: 10.1016/S2352-4642(20)30109-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30109-7</ArticleId><ArticleId IdType="pmc">PMC7156240</ArticleId><ArticleId IdType="pubmed">32302537</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Osta A, et al. How is the COVID-19 lockdown impacting the mental health of parents of school-age children in the UK? A cross-sectional online survey. BMJ Open. 2021;11:e043397. doi: 10.1136/bmjopen-2020-043397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043397</ArticleId><ArticleId IdType="pmc">PMC8117442</ArticleId><ArticleId IdType="pubmed">33980516</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS.UK. Updated JCVI Guidance For The Vaccination of Children And Young People. https://www.england.nhs.uk/coronavirus/documents/updated-jcvi-guidance-for-the-vaccination-of-children-and-young-people/ (2021).</Citation></Reference><Reference><Citation>Gov.UK. JCVI Statement on Vaccination of Children Aged 5 to 11 Years Old. https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-aged-5-to-11/jcvi-statement-on-vaccination-of-children-aged-5-to-11-years-old (2024).</Citation></Reference><Reference><Citation>GOV.WALES. Written Statement: COVID-19 Vaccination&#x2014;JCVI &amp; Chief Medical Officers&#x2019; Advice on Vaccinating 12&#x2013;15 Year Olds. https://www.gov.wales/written-statement-covid-19-vaccination-jcvi-chief-medical-officers-advice-vaccinating-12-15-year (2021).</Citation></Reference><Reference><Citation>Rudan, I. et al. The COVID-19 pandemic in children and young people during 2020-2021: a complex discussion on vaccination. J. Glob. Health11, 01011 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763337</ArticleId><ArticleId IdType="pubmed">35047183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gov.UK. JCVI Statement On COVID-19 Vaccination Of Children And Young People Aged 12 to 17 Years.https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years/jcvi-statement-on-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years-4-august-2021 (2021).</Citation></Reference><Reference><Citation>Gov.UK. Universal Vaccination Of Children And Young People Aged 12 to 15 Years Against COVID-19. https://www.gov.uk/government/publications/universal-vaccination-of-children-and-young-people-aged-12-to-15-years-against-covid-19 (2021).</Citation></Reference><Reference><Citation>WHO. Coronavirus (COVID-19) Latest Insights.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/vaccines (2021).</Citation></Reference><Reference><Citation>Aiano F, et al. Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, august 2021&#x2013;january 2022, England. BMJ Open. 2023;13:e071707. doi: 10.1136/bmjopen-2023-071707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-071707</ArticleId><ArticleId IdType="pmc">PMC10546110</ArticleId><ArticleId IdType="pubmed">37775287</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCuir J, et al. COVID-19 vaccine provider availability and vaccination coverage among children aged 5&#x2013;11 years &#x2014; United States, november 1, 2021&#x2013;april 25, 2022. MMWR Morb. Mortal. Wkly Rep. 2022;71:847&#x2013;851. doi: 10.15585/mmwr.mm7126a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7126a3</ArticleId><ArticleId IdType="pubmed">35771688</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy NC, et al. Disparities in first dose COVID-19 vaccination coverage among children 5&#x2013;11 years of age, United States. Emerg. Infect. Dis. 2022;28:986&#x2013;989. doi: 10.3201/eid2805.220166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2805.220166</ArticleId><ArticleId IdType="pmc">PMC9045440</ArticleId><ArticleId IdType="pubmed">35226801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KH, et al. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents. Ann. Med. 2023;55:2232818. doi: 10.1080/07853890.2023.2232818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2232818</ArticleId><ArticleId IdType="pmc">PMC10351440</ArticleId><ArticleId IdType="pubmed">37449878</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinnon B, Quach C, Dub&#xe9; &#xc8;, Tuong Nguyen C, Zinszer K. Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada. Vaccine. 2021;39:7140&#x2013;7145. doi: 10.1016/j.vaccine.2021.10.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.10.077</ArticleId><ArticleId IdType="pmc">PMC8573666</ArticleId><ArticleId IdType="pubmed">34763947</ArticleId></ArticleIdList></Reference><Reference><Citation>Valier M. R. Racial and ethnic differences in COVID-19 vaccination coverage among children and adolescents aged 5&#x2013;17 years and parental intent to vaccinate their children&#x2014;National Immunization Survey&#x2013;Child COVID Module, United States, December 2020&#x2013;September 2022. MMWR Morb. Mortal Wkly Rep. 72, 1&#x2013;8 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815155</ArticleId><ArticleId IdType="pubmed">36602930</ArticleId></ArticleIdList></Reference><Reference><Citation>VanWormer JJ, Alicea G, Weichelt BP, Berg RL, Sundaram ME. COVID-19 vaccine coverage disparities in rural and farm children. Vaccine. 2023;41:68&#x2013;75. doi: 10.1016/j.vaccine.2022.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.11.015</ArticleId><ArticleId IdType="pmc">PMC9659554</ArticleId><ArticleId IdType="pubmed">36400661</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos VS, Siqueira TS, Silva JRS, Gurgel RQ. Spatial clustering of low rates of COVID-19 vaccination among children and adolescents and their relationship with social determinants of health in Brazil: a nationwide population-based ecological study. Public Health. 2023;214:38&#x2013;41. doi: 10.1016/j.puhe.2022.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.10.024</ArticleId><ArticleId IdType="pmc">PMC9626441</ArticleId><ArticleId IdType="pubmed">36470038</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Netw. Open. 2023;6:e2253590. doi: 10.1001/jamanetworkopen.2022.53590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.53590</ArticleId><ArticleId IdType="pmc">PMC9887489</ArticleId><ArticleId IdType="pubmed">36716029</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. Comparing The Risk Of Death Involving Coronavirus (COVID-19) By Variant, England (ONS, 2021).</Citation></Reference><Reference><Citation>ONS. Regional and Sub-Regional Estimates of Coronavirus (COVID-19) Positivity Over Time, UK: 12 January 2023 (ONS, 2021).</Citation></Reference><Reference><Citation>Khatatbeh M, et al. Children&#x2019;s rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the eastern Mediterranean region. BMC Public Health. 2022;22:1375. doi: 10.1186/s12889-022-13798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13798-2</ArticleId><ArticleId IdType="pmc">PMC9294741</ArticleId><ArticleId IdType="pubmed">35850675</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazel M, et al. Willingness of children and adolescents to have a COVID-19 vaccination: results of a large whole schools survey in England. EClinicalMedicine. 2021;40:101144. doi: 10.1016/j.eclinm.2021.101144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101144</ArticleId><ArticleId IdType="pmc">PMC8482530</ArticleId><ArticleId IdType="pubmed">34608453</ArticleId></ArticleIdList></Reference><Reference><Citation>KFF. COVID-19 Vaccine Monitor: Winter 2021 Update On Parents&#x2019; Views Of Vaccines For Kids. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-winter-2021-update-on-parents-views-of-vaccines/ (2021).</Citation></Reference><Reference><Citation>Vidgen B., Taylor H., Bereskin C. &amp; Margetts H. Understanding Parental Concerns about COVID-19 Vaccination (The Alan Turing Institute, 2024).</Citation></Reference><Reference><Citation>Jones, B., Wardman, L. &amp; Tinkler, L. Coronavirus Vaccine Hesitancy In Younger Adults. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/articles/coronavirusvaccinehesitancyinyoungeradults/ (2021).</Citation></Reference><Reference><Citation>Ceannt R, Vallieres F, Burns H, Murphy J, Hyland P. Covid-19 vaccine hesitancy and resistance amongst parents of children under 18 years of age in Ireland. Vaccine. 2022;40:6196&#x2013;6200. doi: 10.1016/j.vaccine.2022.08.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.08.073</ArticleId><ArticleId IdType="pmc">PMC9448701</ArticleId><ArticleId IdType="pubmed">36127211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson S, et al. To be or not to be vaccinated against COVID-19&#x2014;the adolescents&#x2019; perspective&#x2014;a mixed-methods study in Sweden. Vaccine: X. 2021;9:100117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524812</ArticleId><ArticleId IdType="pubmed">34693273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedston S, et al. COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: a national prospective cohort study in Wales. Vaccine. 2022;40:1180&#x2013;1189. doi: 10.1016/j.vaccine.2021.11.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.11.061</ArticleId><ArticleId IdType="pmc">PMC8760602</ArticleId><ArticleId IdType="pubmed">35042645</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. Coronavirus (COVID-19) Latest Insights. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/vaccines (2023).</Citation></Reference><Reference><Citation>Levy M, et al. Multisystem Inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327:281&#x2013;283. doi: 10.1001/jama.2021.23262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.23262</ArticleId><ArticleId IdType="pmc">PMC8689418</ArticleId><ArticleId IdType="pubmed">34928295</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161&#x2013;4164. doi: 10.1016/j.vaccine.2015.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa, et al. Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open. 2016;6:e011092. doi: 10.1136/bmjopen-2016-011092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011092</ArticleId><ArticleId IdType="pmc">PMC4838708</ArticleId><ArticleId IdType="pubmed">27098827</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CR, et al. Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II): protocol for an observational study using linked scottish national data. BMJ Open. 2020;10:e039097. doi: 10.1136/bmjopen-2020-039097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039097</ArticleId><ArticleId IdType="pmc">PMC7311023</ArticleId><ArticleId IdType="pubmed">32565483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons RA, et al. The SAIL databank: linking multiple health and social care datasets. BMC Med. Inform. Decis. Mak. 2009;8:3. doi: 10.1186/1472-6947-9-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-9-3</ArticleId><ArticleId IdType="pmc">PMC2648953</ArticleId><ArticleId IdType="pubmed">19149883</ArticleId></ArticleIdList></Reference><Reference><Citation>Piernas C, et al. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2022;10:571&#x2013;580. doi: 10.1016/S2213-8587(22)00158-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00158-9</ArticleId><ArticleId IdType="pmc">PMC9246477</ArticleId><ArticleId IdType="pubmed">35780805</ArticleId></ArticleIdList></Reference><Reference><Citation>Glampson B, et al. Assessing COVID-19 vaccine uptake and effectiveness through the north west London vaccination program: retrospective cohort study. JMIR Public Health Surveill. 2021;7:e30010. doi: 10.2196/30010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30010</ArticleId><ArticleId IdType="pmc">PMC8451961</ArticleId><ArticleId IdType="pubmed">34265740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lintu MK, Shreyas KM, Kamath A. A multi-state model for kidney disease progression. Clin. Epidemiol. Glob. Health. 2022;13:100946. doi: 10.1016/j.cegh.2021.100946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2021.100946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazewinkel AD, et al. Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American osteosarcoma Study) randomised clinical trial. BMJ Open. 2022;12:e053083. doi: 10.1136/bmjopen-2021-053083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053083</ArticleId><ArticleId IdType="pmc">PMC8900028</ArticleId><ArticleId IdType="pubmed">35246418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocquier A, Cortaredona S, Fressard L, Galtier F, Verger P. Seasonal influenza vaccination among people with diabetes: influence of patients&#x2019; characteristics and healthcare use on behavioral changes. Hum. Vaccin. Immunother. 2020;16:2565&#x2013;2572. doi: 10.1080/21645515.2020.1729628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1729628</ArticleId><ArticleId IdType="pmc">PMC7644174</ArticleId><ArticleId IdType="pubmed">32209014</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221. doi: 10.1136/bmj.c221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c221</ArticleId><ArticleId IdType="pubmed">20139215</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal U, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400:1305&#x2013;1320. doi: 10.1016/S0140-6736(22)01656-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01656-7</ArticleId><ArticleId IdType="pmc">PMC9560746</ArticleId><ArticleId IdType="pubmed">36244382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr S, et al. Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. Int. J. Epidemiol. 2023;52:22&#x2013;31. doi: 10.1093/ije/dyac199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac199</ArticleId><ArticleId IdType="pmc">PMC9620314</ArticleId><ArticleId IdType="pubmed">36272418</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau T. M. A Package For Survival Analysis In R.https://CRAN.R-project.org/package=survival (2020).</Citation></Reference><Reference><Citation>Wreede L., Fiocco M. &amp; Putter H. mstate: An R package for the analysis of competing risks and multi-state models. J. Stat. Softw.38, 1&#x2013;30 (2011).</Citation></Reference><Reference><Citation>Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Soft10.18637/jss.v036.i03 (2010).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>